Pantoprazole Sodium · PANTOPRAZOLE SODIUM 40 mg/10mL · Injection, Powder, For Solution · Intravenous · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
NDC 00008-0923-60 · 25 CARTON in 1 PACKAGE / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL · NDA · View full market →
13 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.7% of the time — roughly 4× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · price up 28% YoY · OAI inspection at a producing facility (24 months)
For scale: the typical drug’s chance is about 0.1% — this one is 4× that.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NPP | Aug 12, 2027 |
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 3, 2026 |
| BE Pharmaceuticals Inc. | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | PANTOPRAZOLE SODIUM 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Cardinal Health 107, LLC | PANTOPRAZOLE SODIUM 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Devatis Inc. | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | PANTOPRAZOLE SODIUM 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northstar Rx LLC | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Piramal Critical Care | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Takeda GmbH | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Wasserburger Arzneimittelwerk GmbH | PANTOPRAZOLE SODIUM 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | PANTOPRAZOLE SODIUM 40 mg/10mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Protonix I.V. — NDC 00008-0923-60," retrieved September 3, 2026, https://drugdashboards.com/drug/00008092360.
Free to cite with attribution — see how the data is put together.